<DOC>
	<DOCNO>NCT02771405</DOCNO>
	<brief_summary>The study recruit 150 patient HCV related HCC , HCC treatment patient undergo treatment different regimen DAAs .</brief_summary>
	<brief_title>Impact Interferon Free Regimens Patients With Chronic HCV Successfully Treated HCC</brief_title>
	<detailed_description>The study recruit 150 patient HCV relate HCC All study patient underwent undergo one curative intervention HCC either hepatic resection thermal ablation . 1 month achievement laboratory radiological response HCC intervention patient treat one interferon free regimen : 1 . Sofosbuvir+Ribavirin 2 . Sofosbuvir+Simeprevir± Ribavirin 3 . Sofosbuvir+ Daclatasvir ± Ribavirin 4 . Sofosbuvir+ Ledipasvir ± Ribavirin treatment duration justify either 12 24 week treatment patient continue regular follow detect HCV cure recurrence , HCC cure recurrence long term follow natural history</detailed_description>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Simeprevir</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<mesh_term>Ledipasvir</mesh_term>
	<criteria>Age 1870 year old Confirmed HCV viremia PCR CHILD Pugh `` A '' `` B7 , B8 '' Confirmed HCC either laboratory , image histopathological criterion Underwent candidate curative intervention HCC ( BCLC stage 0 , A ) Willing treat HCV sign informed consent Patients 18 70 year old patient advance liver condition `` CHILD score ≥ B9 '' Patients advance HCC status ( BCLC≥ B ) Patients combined HBV , HIV infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>HCV-HCC-DAAs</keyword>
</DOC>